Kiromic Biopharma Inc Financial Flexibility Index
Kiromic Biopharma Inc financial flexibility index. Kiromic Biopharma Inc (KRBP) has a Financial Flexibility Index of -0.17x as of December 2024. Free cash flow of $-3.62 Million (operating CF $-3.65 Million minus capex $28.00K) represents 0% of total liabilities ($21.13 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Kiromic Biopharma Inc (2018–2024)
Financial flexibility index of Kiromic Biopharma Inc from 2018 to 2024. Historical Financial Flexibility Index trend for Kiromic Biopharma Inc across 7 annual periods. Explore Kiromic Biopharma Inc (KRBP) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Kiromic Biopharma Inc Financial Flexibility Index by Year (2018–2024)
Kiromic Biopharma Inc financial flexibility index by year from 2018 to 2024. Year-by-year free cash flow to debt coverage for Kiromic Biopharma Inc. For the full cash flow conversion analysis, see Kiromic Biopharma Inc (KRBP) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.90x | $-19.09 Million | $-19.46 Million | $21.13 Million | ▲ +8.5% |
| 2023 | -0.99x | $-21.02 Million | $-21.23 Million | $21.29 Million | ▲ +7.2% |
| 2022 | -1.06x | $-18.87 Million | $-23.75 Million | $17.74 Million | ▲ +80.3% |
| 2021 | -5.40x | $-18.43 Million | $-20.32 Million | $3.41 Million | ▼ -69.9% |
| 2020 | -3.18x | $-4.67 Million | $-6.13 Million | $1.47 Million | ▲ +17.9% |
| 2019 | -3.88x | $-2.61 Million | $-2.91 Million | $673.70K | ▼ -17.4% |
| 2018 | -3.30x | $-2.02 Million | $-2.15 Million | $610.70K | — |